FamiCord AG (FRA:V3V)

Market Cap	50.38M -56.9%
Revenue (ttm)	87.58M +2.2%
Net Income	-5.84M
EPS	-0.32
Shares Out	n/a
PE Ratio	n/a
Forward PE	167.93
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	2.810
Previous Close	2.800
Day's Range	2.810 - 2.810
52-Week Range	2.580 - 7.650
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About FamiCord AG

FamiCord AG engages in the collection, processing, storage, and distribution of cells, tissues, blood, and blood components for medical applications in Germany, Poland, Switzerland, Portugal, and internationally. The company operates through Subgroup Vita 34 And Subgroup PBKM segments. It produces and develops advanced therapies, genetic tests, and analyses for third parties. The company also engages in the development and manufacture of cell and tissue-based products and pharmaceuticals, including the production of viral vectors or comparable ...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1997
• Employees: 723
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: V3V

Financial Performance

In 2025, FamiCord AG's revenue was 88.17 million, an increase of 7.29% compared to the previous year's 82.18 million. Losses were -6.30 million, -48.06% less than in 2024.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 27, 2026

Data Sources Report a data error